Blind E, Raue F, Zisterer A, Kohl B, Ziegler R
Abteilung Innere Medizin I, Medizinische Universitätsklinik Heidelberg.
Dtsch Med Wochenschr. 1990 Nov 16;115(46):1739-45. doi: 10.1055/s-2008-1065219.
Serum-calcium levels were determined in 9666 hospital inpatients during one year. Hypercalcaemia was present in 101 patients (51 women, 50 men, mean age 57 years). In 46 patients, hypercalcaemia was caused by malignancy. The second commonest cause was primary hyperparathyroidism (pHPT) in 35 cases. In the other 20 patients, hypercalcaemia was related to thiazid medication (8 patients), elevated 25-hydroxy-vitamin-D3-levels (six patients) or immobilisation (two patients). In four patients, no cause was found. Intact parathyroid hormone levels reliably distinguished patients with pHPT (values greater than 60 ng/l) from patients with hypercalcaemia of other causes (values less than 40 ng/l). Other laboratory tests were less useful. Serum-calcium levels greater than 2.9 mmol/l were found only in pHPT and hypercalcaemia of malignancy. In pHPT, the medical history frequently revealed nephrolithiasis (12 patients) and gastrointestinal ulcers (8 patients), whereas weight loss was far more common in hypercalcaemia of malignancy (28 patients).
一年内对9666名住院患者测定了血清钙水平。101名患者(51名女性,50名男性,平均年龄57岁)存在高钙血症。46名患者的高钙血症由恶性肿瘤引起。第二常见的病因是原发性甲状旁腺功能亢进(pHPT),共35例。另外20名患者中,高钙血症与噻嗪类药物(8例)、25-羟维生素D3水平升高(6例)或制动(2例)有关。4例患者未找到病因。完整甲状旁腺激素水平能可靠地区分pHPT患者(值大于60 ng/l)和其他病因导致的高钙血症患者(值小于40 ng/l)。其他实验室检查的作用较小。血清钙水平大于2.9 mmol/l仅见于pHPT和恶性肿瘤导致的高钙血症。在pHPT患者中,病史常显示有肾结石(12例)和胃肠道溃疡(8例),而体重减轻在恶性肿瘤导致的高钙血症患者中更为常见(28例)。